IDHC - Integrated Diagnostics Holdings PLC
Exchange: London Exchange • Country: Jersey • Currency: USD • Type: Common Stock • ISIN: JE00BLKGSR75
Diagnostic Tests, Radiology Services, Medical Imaging
Integrated Diagnostics Holdings PLC is a leading consumer healthcare company that offers a comprehensive range of medical diagnostics services to patients across the Middle East and Africa. With a robust portfolio of over 3,000 diagnostic pathology tests, the company provides critical insights to healthcare professionals, enabling them to make informed decisions about patient care.
The company's diagnostic capabilities span multiple disciplines, including immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. This extensive range of tests enables healthcare providers to diagnose and monitor a wide range of medical conditions, from infectious diseases to genetic disorders.
In addition to its pathology services, Integrated Diagnostics Holdings PLC also offers a suite of radiology services, including advanced imaging technologies such as positron emission tomography-computed tomography (PET-CT), magnetic resonance imaging (MRI), and computed tomography (CT). The company's radiology services also include mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), providing healthcare professionals with a detailed understanding of patient anatomy and physiology.
The company's operational footprint extends across five countries, including Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia, where it operates a network of state-of-the-art facilities, including cath lab facilities. With a strong presence in these markets, Integrated Diagnostics Holdings PLC is well-positioned to meet the growing demand for high-quality diagnostic services in the region.
Founded in 1979, Integrated Diagnostics Holdings PLC has a rich history of innovation and excellence in healthcare. Headquartered in Saint Helier, Jersey, the company continues to invest in cutting-edge technologies and talent, solidifying its position as a leader in the consumer healthcare industry.
For more information about Integrated Diagnostics Holdings PLC, please visit their website at https://www.idhcorp.com.
Drawdown (Underwater) Chart
IDHC Stock Overview
Market Cap in USD | 23,980m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Health Care Services |
TER | 0.00% |
IPO / Inception |
IDHC Stock Ratings
Growth 5y | -45.4 |
Fundamental | 53.8 |
Dividend | 15.0 |
Rel. Performance vs Sector | -0.73 |
Analysts | - |
Fair Price Momentum | 0.50 USD |
Fair Price DCF | 26.11 USD |
IDHC Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | -100.00% |
Payout Consistency | 75.0% |
IDHC Growth Ratios
Growth 12m | 6.64% |
Growth Correlation 12m | 5.8% |
Growth Correlation 3m | 61.4% |
CAGR 5y | -12.51% |
CAGR/Mean DD 5y | -0.36 |
Sharpe Ratio 12m | 0.04 |
Alpha vs SP500 12m | -14.57 |
Beta vs SP500 5y weekly | 0.46 |
ValueRay RSI | 92.51 |
Volatility GJR Garch 1y | 60.38% |
Price / SMA 50 | 15.38% |
Price / SMA 200 | 28.57% |
Current Volume | 86.6k |
Average Volume 20d | 96.2k |
External Links for IDHC Stock
As of October 22, 2024, the stock is trading at USD 0.45 with a total of 86,616 shares traded.
Over the past week, the price has changed by +10.02%, over one month by +30.25%, over three months by +48.27% and over the past year by +14.07%.
According to ValueRays Forecast Model, IDHC Integrated Diagnostics Holdings PLC will be worth about 0.6 in October 2025. The stock is currently trading at 0.45. This means that the stock has a potential upside of +22.22%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 25.6 | 5,584 |
Analysts Target Price | - | - |
ValueRay Target Price | 0.6 | 22.2 |